Association of Hypoadiponectinemia With Impaired Vasoreactivity

By N. Ouchi, M. Ohishi, S. Kihara, T. Funahashi, Tadashi Nakamura, H. Nagaretani, M. Kumada, K. Ohashi, Y. Okamoto, H. Nishizawa and 10 more. HYPERTENSION, 2003

597 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Physiology

View Paper: https://www.semanticscholar.org/paper/c67daf21f81dd87934a9c2f14603e193b0257f5a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Takashi Kadowaki
2. Toshimasa Yamauchi

In Physiology

1. Toshimasa Yamauchi
2. Takashi Kadowaki

Citations in the corpus

• Adiponectin and adiponectin receptors. (2005, background): “To determine the physiological role of adiponectin, we and others have generated adiponectin knockout mice and reported that adiponectin-deficient mice exhibited characteristics of the metabolic syndrome such as insulin resistance, glucose intolerance, hyperlipidemia, and hypertension (35, 45, 46).”
• Mechanisms linking obesity with cardiovascular disease (2006, background): “Endothelium-dependent vasoreactivity is impaired in people with hypoadiponectinaemia, which might be at least one cause of hypertension in visceral obesit”
• Adiponectin: A novel adipokine linking adipocytes and vascular function. (2004, unknown): “Studies of vascular reactivity in aortic rings from adiponectin knockout mice showed reduced vasodilation in response to acetylcholine compared with wild-type mice, but not in response to sodium nitroprusside, indicative of an endothelial signaling defect (26).”